Twelve India-based firms announced a collective $20 billion worth of investments in the United States at the 2026 SelectUSA Investment Summit in National Harbor, Maryland, this week.

The commitments span key sectors including pharmaceuticals, advanced manufacturing, energy infrastructure and emerging technologies, India’s U.S. Embassy said in a news release. The projects are expected to create thousands of jobs in both countries while expanding U.S. production and joint innovation capacity.

“I am proud to advance our goal to double U.S.-India bilateral trade to $500 billion by 2030,” said Ambassador Sergio Gor at the SelectUSA kick-off reception in New Delhi, according to the statement. “Through fair, balanced and mutually beneficial trade, we’re attracting world-class investment to the United States and creating shared prosperity for both nations.”

A large majority of the commitments, totaling $19.1 billion, come from India’s pharmaceutical industry. Additional investments across the steel, connectivity and energy sectors will strengthen critical U.S. industrial capacity and help build more resilient and secure supply chains, India’s U.S. Embassy said.

India-based companies also announced more than $1.1 billion in new greenfield and expansion projects across multiple states to support jobs in manufacturing, technology and engineering. According to the embassy, these announcements exceed the cumulative total of all prior SelectUSA Investment Summit announcements from India and represent the largest number by any country at this year’s summit.

The largest India-based pharmaceutical investment comes from Sun Pharmaceutical’s planned $11.75 billion acquisition of New Jersey-based Organon & Co., according to a fact sheet. Other notable commitments include:

JSW Steel’s plans for commissioning $255 million in modernization projects at its facilities in Ohio and Texas

Abhyuday Group’s investment of more than $900 million across five U.S. sites, creating 1,500 American jobs

Sterlite Technologies’ investment of $100 million, creating up to 500 jobs and supporting AI and telecom infrastructure

Magno Innovation Lab’s investment of $2 million to establish U.S. field operations and support energy sector applications

Indian Institute of Technology Madras Global Research Foundation investment of $4.5 million to establish a U.S. research and collaboration hub in California, with plans for an additional East Coast location

Other international partnerships

Cilcare, a French-U.S. biopharmaceutical company specializing in auditory science, also announced a series of U.S. investments at the SelectUSA Investment Summit.

These include preparation of a clinical trial of the company’s lead candidate for treating tinnitus, CIL001, at Massachusetts General Hospital in Boston; plans to triple laboratory capacity at CBSET in Boston; and the launch of a U.S. operational gateway for international biotechnology firms looking to enter the U.S. market.

In addition, Maryland Gov. Wes Moore announced three new partnerships to promote foreign direct investment and grow Maryland’s economy.

One of them is the creation of a Maryland-Korea Trade Desk, which will provide Maryland with a “dedicated representative at the Korean Embassy to ensure continuous engagement, explore mutual areas for growth, and promote the state as an ideal location for Korean companies,” according to a press release.

Moore also announced the signing of a memorandum of understanding between the Maryland Technology Development Corp. and the Kingdom of Jordan’s Ministry of Digital Economy and Entrepreneurship. The partnership will help connect Jordanian and Maryland startups and create new opportunities for co-investment, startup exchange and international market expansion, the news release said.

Finally, Moore said that Impulse Biomed, a life sciences startup from Cape Town, South Africa, has joined the Maryland Global Gateway S?oft Landing Program and will take space at The LaunchPort, a medtech manufacturing accelerator in Baltimore. Administered by the Maryland Department of Commerce, the program gives international companies the opportunity to test the U.S. market while mitigating risk.

By: DocMemory
Copyright © 2023 CST, Inc. All Rights Reserved